Literature DB >> 34360016

Omega-3 Index and Clinical Outcomes of Severe COVID-19: Preliminary Results of a Cross-Sectional Study.

Rodrigo Zapata B1, José Miguel Müller1, Juan Enrique Vásquez1, Franco Ravera1, Gustavo Lago2, Eduardo Cañón3, Daniella Castañeda3, Madelaine Pradenas3, Muriel Ramírez-Santana4.   

Abstract

The potentially detrimental effects of the worldwide deficiency of Omega-3 fatty acids on the COVID-19 pandemic have been underestimated. The Omega-3 Index (O3I), clinical variables, biometric indices, and nutritional information were directly determined for 74 patients with severe COVID-19 and 10 healthy quality-control subjects. The relationships between the OI3 and mechanical ventilation (MV) and death were analyzed.
Results: Patients with COVID-19 exhibited low O3I (mean: 4.15%; range: 3.06-6.14%)-consistent with insufficient fish and Omega-3 supplement consumption, and markedly lower than the healthy control subjects (mean: 7.84%; range: 4.65-10.71%). Inverse associations were observed between O3I and MV (OR = 0.459; C.I.: 0.211-0.997) and death (OR = 0.28; C.I.: 0.08-0.985) in severe COVID-19, even after adjusting for sex, age, and well-known risk factors.
Conclusion: We present preliminary evidence to support the hypothesis that the risk of severe COVID-19 can be stratified by the O3I quartile. Further investigations are needed to assess the value of the O3I as a blood marker for COVID-19.

Entities:  

Keywords:  COVID-19; Omega-3 Index; Omega-3 fatty acids; inflammation

Year:  2021        PMID: 34360016     DOI: 10.3390/ijerph18157722

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  6 in total

1.  Inverse Association between Omega-3 Index and Severity of COVID-19: A Case-Control Study.

Authors:  Muriel Ramírez-Santana; Rodrigo Zapata Barra; Marcela Ñunque González; José Miguel Müller; Juan Enrique Vásquez; Franco Ravera; Gustavo Lago; Eduardo Cañón; Daniella Castañeda; Madelaine Pradenas
Journal:  Int J Environ Res Public Health       Date:  2022-05-25       Impact factor: 4.614

2.  Circulating polyunsaturated fatty acids and COVID-19: a prospective cohort study and Mendelian randomization analysis.

Authors:  Yitang Sun; Radhika Chatterjee; Akash Ronanki; Kaixiong Ye
Journal:  medRxiv       Date:  2022-02-08

Review 3.  The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review.

Authors:  Afrooz Mazidimoradi; Esmat Alemzadeh; Effat Alemzadeh; Hamid Salehiniya
Journal:  Life Sci       Date:  2022-03-28       Impact factor: 6.780

Review 4.  Potential of Omega 3 Supplementation for Coronavirus Disease 2019 (COVID-19): A Scoping Review.

Authors:  Nanda Nursyifa Fadiyah; Ginna Megawati; Dimas Erlangga Luftimas
Journal:  Int J Gen Med       Date:  2022-04-11

5.  Circulating Polyunsaturated Fatty Acids and COVID-19: A Prospective Cohort Study and Mendelian Randomization Analysis.

Authors:  Yitang Sun; Radhika Chatterjee; Akash Ronanki; Kaixiong Ye
Journal:  Front Med (Lausanne)       Date:  2022-06-16

Review 6.  Effects of nutrients on immunomodulation in patients with severe COVID-19: Current knowledge.

Authors:  Bruna Teixeira da Costa; Glauber Rocha Lima Araújo; Ronaldo Teixeira da Silva Júnior; Luana Kauany de Sá Santos; Vinícius Lima de Souza Gonçalves; Daniel Bastos Alves Lima; Beatriz Rocha Cuzzuol; Jonathan Santos Apolonio; Lorena Sousa de Carvalho; Hanna Santos Marques; Camilo Santana Silva; Isadora de Souza Barcelos; Márcio Vasconcelos Oliveira; Fabrício Freire de Melo
Journal:  World J Crit Care Med       Date:  2022-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.